ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,667.56
      1.34%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Leap Therapeutics Inc (LPTX)

      7. Leap Therapeutics Inc (LPTX) News

      LPTX

      Leap Therapeutics (LPTX)

      Leap Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPTX
      DateTimeSourceHeadlineSymbolCompany
      12/28/20204:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LPTXLeap Therapeutics Inc
      12/22/202010:17AMPR Newswire (US)Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data in Molecular Cancer ResearchNASDAQ:LPTXLeap Therapeutics Inc
      11/23/20207:00AMPR Newswire (US)Leap Therapeutics to Participate at Piper Sandler 32nd Annual Virtual Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      11/12/20207:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/12/20207:00AMPR Newswire (US)Leap Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      11/12/20206:54AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      11/10/20207:00AMPR Newswire (US)Leap Therapeutics to Present at Stifel 2020 Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      11/09/202010:58AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/09/20209:30AMPR Newswire (US)Leap Therapeutics Presents DKN-01 Monotherapy Data at AACR Virtual Special Endometrial Cancer ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      11/09/20208:00AMPR Newswire (US)Leap Therapeutics Presents Updated Data for DKN-01 in Esophagogastric Cancer Patients at SITC 2020 35th Annual MeetingNASDAQ:LPTXLeap Therapeutics Inc
      10/19/20206:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LPTXLeap Therapeutics Inc
      10/15/20207:00AMPR Newswire (US)Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual MeetingNASDAQ:LPTXLeap Therapeutics Inc
      10/14/20205:16PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:LPTXLeap Therapeutics Inc
      09/24/20208:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      09/24/20207:00AMPR Newswire (US)Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Ju...NASDAQ:LPTXLeap Therapeutics Inc
      09/21/20207:00AMPR Newswire (US)Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatm...NASDAQ:LPTXLeap Therapeutics Inc
      09/14/20205:26PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LPTXLeap Therapeutics Inc
      09/10/20205:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      09/09/20207:00AMPR Newswire (US)Leap Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      08/24/20207:00AMPR Newswire (US)Leap Therapeutics Expands Leadership Team with Addition of Two Industry VeteransNASDAQ:LPTXLeap Therapeutics Inc
      08/21/20205:02PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LPTXLeap Therapeutics Inc
      08/13/20207:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      08/13/20207:00AMPR Newswire (US)Leap Therapeutics Reports Second Quarter 2020 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      06/25/20204:05PMPR Newswire (US)Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:LPTXLeap Therapeutics Inc
      06/24/20207:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LPTXLeap Therapeutics Inc
      06/22/20204:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      06/22/20204:05PMPR Newswire (US)Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:LPTXLeap Therapeutics Inc
      06/19/20204:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      06/18/20209:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      06/18/20209:00AMPR Newswire (US)Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded WarrantsNASDAQ:LPTXLeap Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LPTX